Critical care utilisation for patients receiving chimeric antigen receptor (CAR) T cell therapy in the UK.
Pirani, Tasneem Wilson, Anthony Brealey, David Low, Ryan O'Neill, Suzanne Le, Jenny Jhanji, Shaman Bangash, Mansoor N Mathew, Amrith Wright, Christopher
Pirani, Tasneem
Wilson, Anthony
Brealey, David
Low, Ryan
O'Neill, Suzanne
Le, Jenny
Jhanji, Shaman
Bangash, Mansoor N
Mathew, Amrith
Wright, Christopher
Abstract
Critical care utilisation for patients receiving chimeric antigen receptor (CAR) T cell therapy in the UK
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2024-03-22
Type
Article
Subject
Collections
Citation
Pirani T, Wilson A, Brealey D, Low R, O'Neill S, Le J, Jhanji S, Bangash MN, Mathew A, Wright C, Latif AL, Irvine D, Kasipandian V, Singh N, Saha R, Metaxa V. Critical care utilisation for patients receiving chimeric antigen receptor (CAR) T cell therapy in the UK. Br J Anaesth. 2024 May;132(5):1004-1006. doi: 10.1016/j.bja.2024.01.047. Epub 2024 Mar 22.